Primary surgical treatment of T3 glottic carcinoma: long-term results and decision-making aspects.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 22965857.
- Also identified by DOI 10.1002/lary.23580.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this study was to assess the efficacy of primary surgical treatment in the management of T3 glottic carcinomas. Retrospective clinical study. A retrospective evaluation of the records for all patients treated with primary surgery for T3 glottic carcinomas at a tertiary referral center between 1980 and 2005 was carried out. Data for the 5-year disease-specific survival (DSS) were assessed, as well as local control rates in relation to vocal cord immobility, N classification, choice of surgical modality, and adjuvant therapy. Patients who underwent partial laryngectomy were also evaluated in relation to organ preservation and the rate of permanent tracheotomies. The 5-year DSS in the 120 patients was 78.3%. Positive neck disease was shown to be a significant negative prognostic factor. Organ preservation was achieved in 90.1% of the patients who underwent partial laryngectomy and in 50% of the overall patient group. The occult metastasis rate was 14%. Primary surgical treatment is an effective modality against T3 glottic carcinomas. Partial laryngectomy is a reliable method in carefully selected cases. Low complication rates can be expected.
Medical subject headings
- Decision Making
- Glottis
- Laryngeal Neoplasms
- Laryngectomy
- Neoplasm Staging